revealed that MUC16 overexpression in breast cancer alters interactions with JAK2, accelerating the G2/M phase transition of the cell cycle to promote cellular proliferation and apoptosis resistance, while its silencing induces cell cycle arrest and enhances TRAIL-mediated apoptosis (53). Here, MUC16 is linked to breast carcinoma.